Comment by
WalterTheDawg on Apr 18, 2022 4:00pm
I have no real thoughts on long term price. Stem cell adoption by the FDA is still in it's infancy but there are a few approved in Canada. I do have near term targets that are over double todays SP based on how the company will be valued after good to great results from their phase 2 clinical trial and they are very conservative. I'll leave the big dreams to big dreamers.
Comment by
RamboOO7 on Apr 18, 2022 4:38pm
Stems sells would be awesome. Would save a lot of operations $$$$$
Comment by
RamboOO7 on Apr 18, 2022 4:40pm
Volume is picking up.Good sign this can pop high soon.
Comment by
fox7mf on Apr 18, 2022 5:04pm
This could go to +$20 a share and could be a target of a successful post phase 2, pre phase 3 buyout for a couple of B's...IMO. Thomas continually mentioned Myokardia's $13.1b usd buyout, who are in a similar space, and who's science may not even be as strong as ours. While that amount may be 'pie in the sky', I'm holding for wtv the buyout may yield. GLTA!!
Comment by
RamboOO7 on Apr 18, 2022 5:18pm
Yeah that's my thinking.Could be huge world wide !
Comment by
RamboOO7 on Apr 18, 2022 5:55pm
I am interested in adding more shares. I will be watching closely